Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Sherman

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Plos Pathogens|January 5, 2011
Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccinesHannah Priyadarshini Gideon, Katalin Andrea Wilkinson, Tige R Rustad, et al.
Chemistry & Biology|June 24, 2014
Folate pathway disruption leads to critical disruption of methionine derivatives in Mycobacterium tuberculosisMolly R Nixon, Kurt W Saionz, Mi-Sun Koo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2019
Phase variation in <i>Mycobacterium tuberculosis glpK</i> produces transiently heritable drug toleranceHassan Safi, Pooja Gopal, Subramanya Lingaraju, et al.
Tuberculosis (Edinburgh, Scotland)|April 11, 2015
Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screeningKaustuv Nayak, Lichen Jing, Ronnie M Russell, et al.
Diagnostic Microbiology and Infectious Disease|November 6, 2023
Molecular detection of pre-ribosomal RNAs of Mycobacterium bovis bacille Calmette-Guérin and Mycobacterium tuberculosis to enhance pre-clinical tuberculosis drug and vaccine developmentMing Chang, Sambasivan Venkatasubramanian, Holly Barrett, et al.
Mbio|April 5, 2023
A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in CaseumJansy P Sarathy, Min Xie, Richard M Jones, et al.
Nature Communications|January 13, 2015
The DNA-binding network of Mycobacterium tuberculosisKyle J Minch, Tige R Rustad, Eliza J R Peterson, et al.
The Journal of Clinical Investigation|December 3, 2011
The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infectionPhilana Ling Lin, Jes Dietrich, Esterlina Tan, et al.
Plos One|October 3, 2013
Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosisThomas R Ioerger, Theresa O'Malley, Reiling Liao, et al.
The New England Journal of Medicine|August 30, 2018
Bacterial Factors That Predict Relapse after Tuberculosis TherapyRoberto Colangeli, Hannah Jedrey, Soyeon Kim, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Plos Pathogens|January 5, 2011
Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccinesHannah Priyadarshini Gideon, Katalin Andrea Wilkinson, Tige R Rustad, et al.
Chemistry & Biology|June 24, 2014
Folate pathway disruption leads to critical disruption of methionine derivatives in Mycobacterium tuberculosisMolly R Nixon, Kurt W Saionz, Mi-Sun Koo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2019
Phase variation in <i>Mycobacterium tuberculosis glpK</i> produces transiently heritable drug toleranceHassan Safi, Pooja Gopal, Subramanya Lingaraju, et al.
Tuberculosis (Edinburgh, Scotland)|April 11, 2015
Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screeningKaustuv Nayak, Lichen Jing, Ronnie M Russell, et al.
Diagnostic Microbiology and Infectious Disease|November 6, 2023
Molecular detection of pre-ribosomal RNAs of Mycobacterium bovis bacille Calmette-Guérin and Mycobacterium tuberculosis to enhance pre-clinical tuberculosis drug and vaccine developmentMing Chang, Sambasivan Venkatasubramanian, Holly Barrett, et al.
Mbio|April 5, 2023
A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in CaseumJansy P Sarathy, Min Xie, Richard M Jones, et al.
Nature Communications|January 13, 2015
The DNA-binding network of Mycobacterium tuberculosisKyle J Minch, Tige R Rustad, Eliza J R Peterson, et al.
The Journal of Clinical Investigation|December 3, 2011
The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infectionPhilana Ling Lin, Jes Dietrich, Esterlina Tan, et al.
Plos One|October 3, 2013
Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosisThomas R Ioerger, Theresa O'Malley, Reiling Liao, et al.
The New England Journal of Medicine|August 30, 2018
Bacterial Factors That Predict Relapse after Tuberculosis TherapyRoberto Colangeli, Hannah Jedrey, Soyeon Kim, et al.
Pageof 10